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Abstract 
Purpose: To visualize the pancreas in postmortem rats with local contrast medium 
infusion by three dimensional (3D) magnetic resonance imaging (MRI) and computed 
tomography (CT) using clinical imagers.  
Methods: A total of 16 Sprague-Dawley rats about 300g were used for the pancreas 
visualization. Following the baseline imaging, a mixed contrast medium dye called 
GadoIodo-EB containing optimized concentrations of Gd-DOTA, Iomeprol and Evens 
blue was infused into the distally obstructed common bile duct (CBD) for postcontrast 
imaging at 3.0T MRI and 128-slice CT scanners. Images were post-processed with 
MeVisLab software package. MRI findings were co-registered with CT scans and 
validated with histomorphology, with relative contrast ratios quantified. 
Results: Without contrast enhancement, the pancreas was indiscernible. After 
infusion of GadoIodo-EB solution, only pancreatic region became outstandingly 
visible, as shown by 3D rendering MRI and CT and proven by colored dissection and 
histological examinations. The measured volume of the pancreas averaged at 
1.12±0.04cm3 after standardization. Relative contrast ratios were 93.28±34.61% and 
26.45±5.29% for MRI and CT respectively. 
Conclusions:  We have developed a multifunctional contrast medium dye to help 
clearly visualize and delineate rat pancreas in situ using clinical MRI and CT 
scanners. The topographic landmarks thus created with 3D demonstration may help 
to provide guidelines for the next in vivo pancreatic MR imaging research in rodents.  
Key Words: contrast enhanced imaging, rat pancreas, image processing, 3D 
visualization     
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Introduction 
Causative factors on the pancreas result in diseases such as pancreatitis, diabetes, 
and pancreatic tumors (1,2). The high incidence and mortality of pancreatic diseases 
have positioned imaging diagnosis a crucial place in daily clinical practice. 
With the spatial and temporal resolution approaching that of computed tomography 
(CT), magnetic resonance imaging (MRI) has been increasingly utilized in clinic 
diagnosis of pancreatic lesions due to its additional advantages such as superb soft 
tissue contrast, ionizing-radiation free and multiparametric capacity (3,4). The 
combination of basic T1/T2 sequences, diffusion weighted imaging (DWI) and 
contrast enhanced MRI improves the accuracy of diagnosis for pancreatic tumors (5). 
The invention of MR cholangiopancreatography (MRCP) makes noninvasive 
examination of biliopancreatic duct system possible without any post-procedural 
complications (6,7). 
In order to explore the mechanisms of pancreatic pathologies and develop new 
diagnostic and therapeutic techniques, rodent models are often used in pancreatic 
studies. However, unlike pancreas in humans, which is a retroperitoneal solid organ 
and can be identified by imaging even without contrast enhancement (3,8), rodent 
pancreas appears as an irregular lobulated organ, which is indiscernible compared to 
surrounding tissues, making imaging pancreas in rodents extremely challenging 
(9,10). 
Efforts have been made in rodent pancreas MR imaging such as pancreatic islets 
imaging and pancreatic vessels permeability imaging using dynamic contrast 
enhanced MRI (11–13). However, due to the lack of pancreas specific labeling, 
pancreatic tissue in rodents itself is still very difficult to be distinguished from the 
surrounding structures such as caudate liver lobes, omenta and other peri-
gastrointestinal soft tissues. Moreover, even after labeling, it is still challenging to 
have a complete overview of the entire pancreas due to the random movement of 
guts around pancreatic head portion. At this stage, the failure to image the entire 
pancreas has hampered our study on pancreatic diseases (e.g. acute pancreatitis), 
since nil or partial visualization of rodent pancreas could not reflect the overall 
pathological changes. 
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In this study, we intended to image rat pancreas in situ by using the state-of-the-art 
clinical MRI and CT scanners with the assistance of intra-pancreatic contrast 
enhancement. Detailed imaging landmarks and morphometry of rat pancreas were 
measured, described and presented with three dimensional (3D) rendering. Such 
postmortem investigation may help clearly recognize rat pancreas anatomy, provide 
a standard topography of this organ, and pave the way for the next in vivo 3D high 
resolution imaging studies on normal pancreas and pancreatic diseases in rat models.   
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Materials and methods 
This experiment was approved by the ethical committee of our institute for animal 
research and welfare, and performed according to a designed protocol (Fig. 1). 
Animals 
Twelve Sprague-Dawley rats of equal genders weighing between 270 to 350g were 
subjected to both in vivo and postmortem imaging studies after being fasted for 6 
hours prior to the experiments. Additional 4 rats of equal genders were used for 
dissection and histomorphological studies as normal controls. 
Contrast solution preparation, characterization and administration 
For multimodality contrasted imaging visualization of pancreas in rodents, phantoms 
with CT and MRI contrast agents at gradient concentrations and their dye mixtures 
were prepared and screened with CT and MRI. Consequently, a mixed hydrophilic 
solution called GadoIodo-EB containing 2 mM gadolinium contrast agent Gd-DOTA 
(Dotarem®, Guerbet, France) for MRI, Iomeprol (Iomeron®, Bracco, Italy) at 10 mg 
iodine/ml for CT and 0.1% Evans blue (EB, Sigma-Aldrich, USA) diluted in normal 
saline was optimized and made ready for instillation into the biliopancreatic duct at 
0.6 ml per rat to demonstrate the pancreas by CT, MRI and visual inspection. 
Furthermore, such solutions of separate components or as a mixture GadoIodo-EB 
were characterized by high-performance liquid chromatography (UV-Vis HPLC 
detector 190-900 nm, Auckland, New Zealand) for testing their chemical stabilities.  
In vivo MRI   
MRI was performed at a 3.0T clinical scanner (Magnetom Tim Trio, Siemens, 
Erlangen, Germany). MR signal was transmitted through the 60 cm size bore body 
coil with maximum gradient amplitude of 45mT/m and slew rate of 200mT/m/ms, 
which was combined with an 8 channel phase array wrist coil as receiver. In vivo and 
postmortem MRI acquisition parameters are summarized in table 1. For in vivo MR 
scanning, animals were anesthetized by inhalation of 1 to 2 % isoflurane (mixed with 
oxygen and air) and placed in a supine position while images were acquired. MR 
compatible small animal physiological monitoring system (SAII, Stony Brook, NY, 
USA) was applied for respiration triggering. A 0.3 mm isotropic 3D gradient echo 
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flash low angle shot (FLASH) sequence with segmented k-space acquisition and a 
flow compensate T2 weighted 3D turbo spin-echo (TSE) with variable-flip-angle 
refocusing RF pulses (SPACE) sequence were performed.  
Postmortem imaging acquisition   
For preparing postmortem studies, rats were first anesthetized with intraperitoneal 
pentobarbital (Nembutal; Sanofi Sante Animale, Brussels, Belgium) at a dose of 40 
mg/kg. After hair shaving and skin sterilization, a midline incision was made to 
expose the liver and other abdominal organs, particularly the hepatic portal area. To 
block the secretion pathway, the biliopancreatic duct was ligated in close vicinity to 
duodenal papilla, similarly to the technique mentioned in Kare’s study (14). 
Afterwards, a 16 cm silicone catheter of 1.0 mm outer diameter (Degania Silicone Ltd, 
Degania Bet, 1513000, Israel) was inserted 6 mm deep into the common bile duct 
(CBD) near the hepatic port to the direction of duodenum for GadoIodo-EB infusion. 
The catheter was anchored with a 5-0 silk suture and connected to a 1.0 ml syringe 
loaded with the GadoIodo-EB contrast medium dye solution. After closure of 
abdominal incision by two layers of suture, the animal was euthanized by intravenous 
overdose of Nembutal to nullify imaging motion artifacts.  
Following a baseline precontrast MRI scanning, pre- and postcontrast CT images 
were acquired on a clinic CT scanner (Somatom Definition Flash, Siemens, Erlangen, 
Germany) using low tube voltage of 80 kVp, total X-ray exposure time was 53s for 
each scan. High resolution transversal imaging was reconstructed and processed in 
Syngo CT 2012B with matrix size of 512*512, and a slice distance of 0.2 mm. Such 
3D-CT scans allowed imaging rat abdomen on a relatively noise-free background to 
validate the presence of contrast agent in the pancreas (see video-supplement 1). 
Postmortem MRI with 3D FLASH sequence was performed to evaluate the T1 
enhancement by Gd-DOTA with isotropic spatial resolution of 0.3 mm, SPACE 
sequence was applied to acquire high-resolution anatomical information for rat 
abdomen, and ultra-short echo time (UTE) sequence was used to highlight tissues 
with short T2 in abdomen. Such 3D MRI scans enabled not only pancreas depiction 
but also neighboring organ localization (see video-supplement 2).  
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Image processing 
All imaging analyses and visualizations were accomplished in MeVisLab platform 
(www.mevislab.de). CT images were co-registered to MRI space using MeVis Image 
Registration Toolkit (MERIT), in which affine transformation using normalized mutual 
information similarity measurements was applied. Afterwards, contrast enhanced 
pancreas was segmented from subtracted T1-weighted MR imaging and resampled 
CT imaging using fuzzy c-mean spatial classification algorithm with a proper intensity 
threshold, followed by region growing approach with 3D-6 nearest neighbor search. 
Segmented pancreas tissue volume was measured automatically.  
Fat distribution in rat abdomen was delineated by subtracting SPACE scans with and 
without spectral fat saturation. Organs surrounding the pancreas were manually 
contoured or segmented semi-automatically from UTE or SPACE images only for 3D 
demonstration of pancreatic topography. Resampled pre-contrast CT bone image 
was used as background scaffold.  
Tissue preparation and histology  
After acquiring all images, animals were reopened to harvest the pancreas organ 
guided by GadoIodo-EB coloration. Dissection was made along the boundaries of the 
blue dye stained pancreatic tissues. The pancreas was cleaned from fat tissue and 
actual pancreatic volume was measured by immersing tissue into distilled water 
within a metering tank. Tissue was fixed in 10% formalin and embedded for paraffin 
sections. Afterwards, 5 µm thickness slices were stained with hematoxylin and eosin 
(HE) for optical microscopic assessment (Axioskop, Zeiss, Oberkoche, Germany) 
and digital photography to compare pancreatic tissues without and with contrast 
injection.  
Image quality assessment 
Signal intensity (SI) was measured within the pancreatic region, and contrast ratio 
(CR) after GadoIodo-EB infusion was calculated by the following equation: CR = 
[SI(post)-SI(pre)]/SI(pre)*100%. Visibility of the pancreas, splenic vein and CBD on 
both MRI and CT were assessed and summarized. 
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Results 
General aspects 
All experimental procedures were carried out smoothly according to the pre-designed 
protocol (Fig. 1) without accidental loss of animals. The clinical CT and MRI imagers 
were adapted well for the purpose of the present study in rats. No apparent variation 
of the pancreas was observed between male and female rats, although a movable 
kidney and an extra rib on the right were encountered in two individual rats as 
anatomical variations among this population. 
Contrast agent solution characterization 
A representative UV chromatogram of mixed contrast medium dye GadoIodo-EB 
consisting of 2.0 mM Gd-DOTA, 10mg Iodine/ml Iomeprol and 0.1% Evans blue dye 
is shown in Figure 2. The profiles clearly revealed only two peaks whose retention 
times (RTs) perfectly matched with those observed by analyzing separate standard 
solutions of Iomeprol and Evans blue dye (data not shown). The sharp peak 
corresponded to the CT agent Iomeprol with a RT of 1.80±0.01 min. The second 
broad peak with a RT of 5.99±0.02 min referred to Evans blue. Neither in the 
standard solution nor in the mixture of GadoIodo-EB could Gd-DOTA be detected 
due to its structural lack of UV chromospher s for the HPLC technique applied. 
However, both peaks of Iomeprol and Evans blue in the mixture were not altered by 
adding Gd-DOTA, of which the presence was affirmed by the MRI studies, indicating 
that no chemical reactions occurred within the mixture of GadoIodo-EB. Phantom 
studies showed that neither the presence of Gd-DOTA on CT nor Iomeprol on MRI 
changed intrinsic signal intensity of the contrast medium dye at their concentrations 
applied. 
In vivo MRI 
Three dimensional high resolution in vivo MRI without contrast enhancement 
displayed abdominal anatomy that could be useful for searching pancreas-related 
landmarks such as the CBD or biliopancreatic duct and splenic vein. For examples, 
on 3D T2 SPACE image, the CBD and its extending biliopancreatic duct appeared 
with a strong hyperintensity (Fig. 3a, table 2) and hypointense splenic vein was 
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shown in full length, which likely goes along with pancreatic body and tail (Fig. 3b,  
table 2), as revealed by later contrasted postmortem studies.  
Contrast enhanced MRI  
Pre- and postcontrast T1 and T2 MRI images are shown with the same anatomic 
positions. On T1 FLASH image, before contrast infusion, there was no difference of 
signal intensities between the pancreas and surrounding organs (Fig. 3c, table 2). 
After GadoIodo-EB infusion, pancreatic region appeared hyperintense, indicating the 
T1-shortening effect of the gadolinium chelate (Fig. 3d, table 2). On T2 SPACE 
images, the pancreas was virtually invisible (Fig. 3c'). But, hyperintense signal 
intensity appeared after GadoIodo-EB infusion due to the presence of saline solvent 
or long-T2 water (Fig. 3d'), because the low-concentrated Gd-DOTA had negligible 
T2--shortening effects.  
CT findings  
Before contrast instillation, the pancreas was invisible when image density was set to 
a threshold value for bone visualization by experienced radiologists (Fig. 4a, 4b). But, 
the infused GadoIodo-EB provided a clear contrast for pancreas alone, displaying it 
as an outstanding organ in abdomen (Fig. 4a’, b’). In addition to the pancreas, 
hyperdense subjects also existed in the abdominal region on pre-contrast CT scan, 
which were proven as calcified food residues within the fecal pellets located in large 
intestines (Fig. 4b, b’ and video supplements).  
Topographic descriptions 
As shown by postmortem contrasted CT and MRI scans in this study (Fig. 3-5), the 
entire pancreas in rats appears as a “T” shaped structure, but tilted 90° to the right, 
with the short vertical bar (pancreatic head) at least 2 times thicker than the long 
horizontal bar (pancreatic body and tail). The entire rat pancreas locates in the upper 
abdomen at the level either between the 11th thoracic vertebra (T11) and the 2nd 
lumbar vertebra (L2) or between the T12 and L3 with slight individual variations (Fig. 
5b, b’ and video supplements). Similar to that of humans, though not in the same 
proportions, the pancreas in rats can be divided into pancreatic head, body and tail. 
The head is further divided into the biliary portion located along the CBD on the right 
side of portal vein and gastric pylorus, and the duodenal portion largely enclosed by 
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the “C” shaped duodenum to the left of the right kidney. The pancreatic body and tail 
form a horizontal entity that is also called gastrosplenic portion located inferior to the 
stomach to the right of the spleen (14) and left kidney (video supplements). 
Contrasted topography of rat pancreas imaging enabled recognizing a few landmarks 
that may help position the pancreas in rats in vivo as described below:  
1) a 2-cm elongation line from the CBD downwards can be referred as a landmark for 
localizing pancreatic head anterior to the hilum of the right kidney and largely 
wrapped by the duodenal loop (Fig. 3a, 5b’);  
2) pancreatic body and tail locate inferoposterior to the stomach and caudate lobes of 
the liver and adjacent to the anterosuperior part of the left kidney (Fig. 5a, a’);  
3) the entire splenic vein joining to the portal vein goes along with pancreatic body 
and tail to the right of the spleen and in front of the left kidney (Fig. 3b, c, c’). 
Their relative positions are illustrated by color-coded imaging extraction (Fig. 5b’). Fat 
tissues can be confused with the pancreas, which could be differentiated by 
highlighting the fat (in purple color) using fat saturated SPACE images (Fig. 5a, a’). 
Segmented pancreas and its landmarks were shown by 3D rending images using the 
bony thorax as a background scaffold (Fig. 5b, b’ and video supplement 2).   
Dissection and histology  
Under a re-laparotomy for ex vivo examinations, digital photos showed Evans blue 
staining of pancreatic tissues (Fig. 6a). Microscopically, pancreatic exocrine tissue, 
expanded pancreatic duct and endocrine islets of Langerhans were identified with 
H&E stained histology. Except slightly dilated exocrine glandular system, there was 
no significant difference between contrast-infused and control pancreases (Fig. 6b, c).  
Quantitative measurements 
After adjusted normalization, pancreatic volumes measured by imaging and ex vivo 
analysis were 1.12 ± 0.04 cm3 and 1.17 ± 0.10 cm3 respectively, which is in line with 
the pancreas weight about 1.2 g for SD rats ranging from 270 to 450 g of body weight 
as reported by a previous study (15). The relative contrast ratio for post-contrast 
FLASH-MRI and CT images was enhanced by 93.28 ± 34.61 % and 26.45 ± 5.29 % 
respectively compared to pre-contrast images (table 2). 
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Discussion 
One bottleneck of research on pancreatic disorders in rodents is the virtual inability to 
noninvasively detect the lesion on this organ, to monitor the disease progress and to 
follow up the therapies by imaging modalities, which has hampered advances in the 
field. As the first step in our serial efforts, we attempted to visualize rat pancreas 
postmortem by contrast enhanced MRI and CT using clinically available imagers. To 
the best of our knowledge, it is the first time that the in situ rodent pancreas is so 
clearly depicted in terms of its location, dimension, contour and relations to the 
adjacent anatomical structures, which may provide useful clues or landmarks for 
identifying rat pancreas and its pathologies during further in vivo pancreatic imaging 
research.     
Currently, CT is still the most commonly used imaging modality for diagnosis of 
pancreatitis and pancreatic tumors due to its temporal efficiency and unbiased 
contrast compared to MRI (16,17). Therefore, we applied CT for cross-reference to 
our MRI findings.  
The utilization of the clinical MRI and CT scanners in combination with the FDA 
approved contrast agents would make our findings more clinically translational. It also 
demonstrates that clinicians in academic institutes could perform preclinical animal 
experiments without relying on the dedicated equipment for small animals. Since the 
achievable spatial resolution could be limited in comparison to the miniaturized 
animal imagers, certain technical optimization was necessary particularly for imaging 
rat pancreas as a tiny irregular abdominal organ. 
Accordingly, we adapted higher resolution 3D scanning protocols to include as many 
details as possible, though such 3D scans were more time-consuming with higher 
imaging noise relative to 2D scans. In this study, both T1 weighted FLASH and T2 
weighted SPACE protocols were applied for contrasted and structural evaluations 
respectively. Results showed that without regional contrast agent instillation, it was 
impossible to distinguish rodent pancreas from the surrounding tissues through those 
imaging protocols.  
Because a real pancreas-specific contrast agent does not exist, in this study we 
prepared a mixed water-soluble solution GadoIodo-EB that consists of two 
extracellular water-soluble contrast agents, Gd-DOTA for MRI and Iomeprol for CT 
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(18,19) both of which do not undergo intracellular uptake, and a blue dye. Once 
infused, the solution with optimized concentrations of gadolinium and iodine was 
filled into the exocrine glandular system, leading to the striking contrast observed 
only in the pancreas on both MRI and CT scans. The postcontrast inhomogeneity of 
MRI signal within the pancreas reflects such intraorganal distribution pattern of Gd-
DOTA as also evidenced on colored dissection. The mixture of these two contrast 
agents with Evans blue dye did not alter their chemical properties as proven by HPLC. 
Since all these 3 components are nontoxic and intravenously injectable in humans, 
and since imaging and HPLC outcomes in our study have implied their inert chemical 
properties while mixed, GadoIodo-EB as a multifunctional diagnostic agent could be 
combined with interventional procedures e.g. endoscopic retrograde 
cholangiopancreatography (ERCP) and laparoscopic cholecystectomy, etc. for 
multimodality imaging diagnosis and/or intraoperative optical imaging observation. 
Such potential clinical applications warrant further experimental investigations. 
Without local contrast instillation, the pancreas shows the same signal intensity or 
tissue density as the liver does. Thus hepatic caudate lobe, which locates closely 
next to the pancreatic body, could be mistaken as the pancreas in the literature (20).  
Indeed, the pancreas shares similar soft tissue imaging features with other abdominal 
organs on both MRI and CT, even after systematical contrast agent administration. 
Therefore, it is essential to track the pancreas in vivo by carefully navigating through 
certain landmarks including adjacent organs and important vessels on 3D images. 
Thus, guided by the artificially contrasted pancreas in this study, we were able to 
identify a few such useful landmarks including the CBD, splenic vein, caudate liver 
lobes, the stomach, the duodenum, the right and left kidney and the spleen, which 
together make the in-between contour of pancreas. Abdominal fat tissues in rats 
especially those adhered to the pancreas could be distinguished by using fat-
saturation MRI sequences. However, omentum tissues appeared more difficult to 
identify, which could only be recognized on histology.   
MRI is known to be superior to CT in soft tissue contrast, but the plain scans of both 
modalities proved insufficient to visualize rodent pancreas, and the use of contrast 
agents was deemed necessary. For this, two obstacles should be tackled. First, since 
pancreas-specific contrast agents do not exist, we had to use commercially available 
nonspecific ones such as Gd-DOTA and Iomeprol for MRI and CT respectively. They 
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are made for intravenous injection at a high concentration. After administration they 
undergo extracellular distribution without intracellular uptake, and tissues or organs 
are properly enhanced by them at much diluted concentrations. If without dilution, the 
presence of CT or MRI contrast agents at their original concentrations (0.5M for Gd-
DOTA and 300mg Iodine/ml for Iomeprol) in the scanned volume would cause strong 
artifacts that would mask the authentic images. This was the reason why we had to 
perform in vitro tests first to optimize the mixed contrast dye GadoIodo-EB for the 
appropriate concentrations of both Gd-DOTA and Iomeprol. Secondly, the presence 
of such a contrast dye had to be confined only in the pancreas but not elsewhere to 
selectively enhance this organ on both CT and MR images. To do so, we took 
advantage of the biliopancreatic anatomy in rats and filled the pancreatic exocrine 
ductal system entirely with GadoIodo-EB so that only the pancreas could be 
outstandingly enhanced on both CT and MRI. 
In order to avoid blooming effect while maintaining adequate contrast enhancement, 
the concentration of each contrast agent used in this study was optimized to a 
clinically acceptable range. The total volume of GadoIodo-EB for infusion into the 
pancreas was also controlled to less than the total volume of pancreas.  
There were rodent pancreatic imaging using micro-CT (9), and specific pancreatic 
labeling using high-resolution SPECT technique (21). Contrast enhanced MRI 
suffered from motion artifact due to the special location of pancreas (22). As 
observed by both imaging and histology, pancreatic head was closely surrounded by 
duodenum and attached to the large intestine, wher  the wave movement was 
unpredictable and cannot be monitored, which leads to blurring artifact of the entire 
region. Therefore, fasting is preferred prior to in vivo imaging to reduce gut 
movements. Besides, fasting for 6 hours leaves more upper abdominal space for 
GadoIodo-EB infusion and eases surgical operation. More specific enhancement on 
inflamed pancreas (23) or pancreatic islets surface reporter (24) may help improve 
the imaging accuracy on the pancreas, however such specific contrast agents are still 
unavailable.  
From our in vivo observations, without contrast enhancement, the CBD showed 
prominent hyperintense on SPACE images. Pancreatic ducts, on the other hand, 
were difficult to highlight due to the limited spatial resolution. Although there are 
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abundant blood supplies to the pancreas, only the splenic vein was thick enough to 
be observed by our imaging sequences. Therefore, it seems also essential for in vivo 
pancreas imaging to apply a contrast agent, ideally a pancreas-specific one.  
In conclusion, visualization of a complete pancreas was achieved through contrast 
enhanced CT and MRI imaging in a novel rat postmortem model. Detailed pancreatic 
landmarks were thus described and demonstrated with 3D rendering, including the 
depicted CBD and splenic vein on in vivo images. To identify other in vivo features of 
rodent pancreas, contrast enhanced protocols will be elaborated in the future. 
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Table 1 MR sequence parameters  
 In Vivo   Post mortem 
Sequence 3D FLASH SPACE   3D FLASH SPACE UTE 
Matrix 256*256*160 256*256*160   256*256*144 256*256*144 176*176*176 
Resolution (mm) 0.29*0.29*0.3 0.29*0.29*0.3   0.29*0.29*0.3 0.29*0.29*0.3 0.43*0.43*0.43 
Bandwidth (Hz/pixel) 275 260   260 230 507 
TE (ms) 3.69 144   3.69 132 0.07 
TR (ms) 487.01 1500   13.74 1500 8.28 
Fat saturation - -/+   - -/+ - 
Flip angles (degree) 10 variable   10 variable 15 
Averages 1 2   1 1.4 1 
GRAPPA 2 3   2 2 off 
Phase Partial Fourier off 67%   off 70% off 
Number of Phase Encoding Steps 256 176   256 183 36000 
Scanning time 7 min 14 min   5 min 8 s 11 min 10 s 4 min 59 s 
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Table 2 Qualitative and quantitative image assessment 
Objects MRI in vivo/pre- MRI post- CT pre- CT post- 
Contrast Ratio % 
Pancreas NA 93.28 ± 34.61 % NA 26.45 ± 5.29 % 
Visibility 
Pancreas ?/12 12/12 0/12 12/12 
Splenic Vein 12/12 NA 0/12 0/12 
CBD 12/12 NA 0/12 0/12 
      Note: pre-: precontrast; post-: postcontrast; NA: not applicable; ?: uncertain.
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Figure legends: 
Figure 1 Flowchart of experimental protocol. n: number of rats; CBD: common bile 
duct; MRI: magnetic resonance imaging; CT: computed tomography; GadoIodo-EB: 
Gd-DOTA, monomeric iodinated contrast agent Iomeprol and Evans blue solution.  
Figure 2 Component chemical structures, vial outlook and HPLC UV-chromatogram 
of the mixed contrast medium dye solution GadoIodo-EB. On HPLC, Iomeprol first 
appeared at a retention time (RT) of 1.80±0.01 min and Evans blue dye came out 
with a RT of 5.99±0.02 min, identical to the respective RT when measured alone. The 
chemical structure of Gd-DOTA did not allow its detection by the applied HPLC 
method. 
Figure 3 Coronal display of rat abdomen. a&b: In vivo T2 SPACE MRI for the 
common bile duct (CBD) and splenic vein. Hyperintense CBD and its distal extension 
of biliopancreatic duct (thick arrow) initiated from the hepatic hilum and extended to 
the gut (a), and hypointense splenic vein (thin arrow) merged into the portal vein (b). 
c-d': Postmortem MRI before and after GadoIodo-EB infusion. Pancreatic tissue 
could not be observed before contrast infusion on both T1 FLASH (c) and T2 SPACE 
(c’) images. Gd-DOTA in GadoIodo-EB solution induced contrast enhancement of 
the pancreas on T1 FLASH image (d), which corresponding to increased signal 
intensity on T2 SPACE image (d’) due to the long T2 water in the solvent. 
Hyperintense pancreatic region outline in FLASH image is delineated by green 
dashed line, the same outline is overlaid to SPACE image. 
Figure 4 Pre- (a, b) and postcontrast (a’, b’) CT images: after GadoIodo-EB infusion , 
the pancreas was clearly shown in the middle of the abdomen on 2D image as 
indicated by arrows and in 3D rendering of postcontrast image. The granules (dashed 
circle) appeared on both pre- and postcontrast scans, indicative of calcified residuals 
of feces in the gut. 
Figure 5 Three dimensional demonstration of postmortem T2 SPACE MRI with color 
coded orthoview of the pancreas (green) and fat distribution (purple) in rat abdomen 
at sagittal, coronal and transverse slice snaps: a. at the plane across pancreatic head, 
body and tail; a’. at the plane only across pancreatic head and tail. The surrounding 
topographic landmarks include stomach (St), caudate liver lobe (Cl), spleen (Sp), 
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right kidney (Rk), left kidney (Lk), and duodenum (Du). Arrows indicate fat tissue 
adjacent to the pancreas, which is otherwise difficult to distinguish. 
Three dimensional rendering topography of the pancreas in rats using re-sampled CT 
to generate bony background scaffold: b. only the pancreas (green) was segmented 
and displayed due to GadoIodo-EB infusion; b’. organs surrounding the pancreas 
(green) were displayed to provide anatomic landmarks including the common bile 
duct (yellow), portal vein (blue), splenic vein (red), spleen (Sp, purple); stomach (St, 
bright grey), kidney (K, cabbage green), and guts (dark grey) with ascending colon 
(Ac), transverse colon (Tc) and descending colon (Dc).  
Figure 6 Dissection and histology: a. digital photograph during autopsy displayed the 
pancreas as an Evans blue stained area adjacent to the stomach (St) and duodenum 
(Du); b&c. H&E stained microscopic view from GadoIodo-EB infused (b) and normal 
(c) pancreatic slices. Arrows indicate exocrine pancreatic tissues and arrowhead 
points to a pancreatic duct, and asterisks refer to islets of Langerhans. Scale bar: 50 
µm. 
Supplemental Digital Content 1 Video that demonstrates pre- and postcontrast CT 
images with 360° rotation. 
Supplemental Digital Content 2 Video that rotationally demonstrates postcontrast 
MRI of segmented pancreas and surrounding topographic landmarks with precontrast 
CT bony thorax used as background scaffold. Refers to Fig. 5 for color coding.  
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Abstract 
Purpose: To visualize the pancreas in postmortem rats with local contrast medium 
infusion by three dimensional (3D) magnetic resonance imaging (MRI) and computed 
tomography (CT) using clinical imagers.  
Methods: A total of 16 Sprague-Dawley rats about 300g were used for the pancreas 
visualization. Following the baseline imaging, a mixed contrast medium dye called 
GadoIodo-EB containing optimized concentrations of Gd-DOTA, Iomeprol and Evens 
blue was infused into the distally obstructed common bile duct (CBD) for postcontrast 
imaging at 3.0T MRI and 128-slice CT scanners. Images were post-processed with 
MeVisLab software package. MRI findings were co-registered with CT scans and 
validated with histomorphology, with relative contrast ratios quantified. 
Results: Without contrast enhancement, the pancreas was indiscernible. After 
infusion of GadoIodo-EB solution, only pancreatic region became outstandingly 
visible, as shown by 3D rendering MRI and CT and proven by colored dissection and 
histological examinations. The measured volume of the pancreas averaged at 
1.12±0.04cm3 after standardization. Relative contrast ratios were 93.28±34.61% and 
26.45±5.29% for MRI and CT respectively. 
Conclusions:  We have developed a multifunctional contrast medium dye to help 
clearly visualize and delineate rat pancreas in situ using clinical MRI and CT 
scanners. The topographic landmarks thus created with 3D demonstration may help 
to provide guidelines for the next in vivo pancreatic MR imaging research in rodents.  
Key Words: contrast enhanced imaging, rat pancreas, image processing, 3D 
visualization     
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Introduction 
Causative factors on the pancreas result in diseases such as pancreatitis, diabetes, 
and pancreatic tumors (1,2). The high incidence and mortality of pancreatic diseases 
have positioned imaging diagnosis a crucial place in daily clinical practice. 
With the spatial and temporal resolution approaching that of computed tomography 
(CT), magnetic resonance imaging (MRI) has been increasingly utilized in clinic 
diagnosis of pancreatic lesions due to its additional advantages such as superb soft 
tissue contrast, ionizing-radiation free and multiparametric capacity (3,4). The 
combination of basic T1/T2 sequences, diffusion weighted imaging (DWI) and 
contrast enhanced MRI improves the accuracy of diagnosis for pancreatic tumors (5). 
The invention of MR cholangiopancreatography (MRCP) makes noninvasive 
examination of biliopancreatic duct system possible without any post-procedural 
complications (6,7). 
In order to explore the mechanisms of pancreatic pathologies and develop new 
diagnostic and therapeutic techniques, rodent models are often used in pancreatic 
studies. However, unlike pancreas in humans, which is a retroperitoneal solid organ 
and can be identified by imaging even without contrast enhancement (3,8), rodent 
pancreas appears as an irregular lobulated organ, which is indiscernible compared to 
surrounding tissues, making imaging pancreas in rodents extremely challenging 
(9,10). 
Efforts have been made in rodent pancreas MR imaging such as pancreatic islets 
imaging and pancreatic vessels permeability imaging using dynamic contrast 
enhanced MRI (11–13). However, due to the lack of pancreas specific labeling, 
pancreatic tissue in rodents itself is still very difficult to be distinguished from the 
surrounding structures such as caudate liver lobes, omenta and other peri-
gastrointestinal soft tissues. Moreover, even after labeling, it is still challenging to 
have a complete overview of the entire pancreas due to the random movement of 
guts around pancreatic head portion. At this stage, the failure to image the entire 
pancreas has hampered our study on pancreatic diseases (e.g. acute pancreatitis), 
since nil or partial visualization of rodent pancreas could not reflect the overall 
pathological changes. 
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In this study, we intended to image rat pancreas in situ by using the state-of-the-art 
clinical MRI and CT scanners with the assistance of intra-pancreatic contrast 
enhancement. Detailed imaging landmarks and morphometry of rat pancreas were 
measured, described and presented with three dimensional (3D) rendering. Such 
postmortem investigation may help clearly recognize rat pancreas anatomy, provide 
a standard topography of this organ, and pave the way for the next in vivo 3D high 
resolution imaging studies on normal pancreas and pancreatic diseases in rat models.   
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Materials and methods 
This experiment was approved by the ethical committee of our institute for animal 
research and welfare, and performed according to a designed protocol (Fig. 1). 
Animals 
Twelve Sprague-Dawley rats of equal genders weighing between 270 to 350g were 
subjected to both in vivo and postmortem imaging studies after being fasted for 6 
hours prior to the experiments. Additional 4 rats of equal genders were used for 
dissection and histomorphological studies as normal controls. 
Contrast solution preparation, characterization and administration 
For multimodality contrasted imaging visualization of pancreas in rodents, phantoms 
with CT and MRI contrast agents at gradient concentrations and their dye mixtures 
were prepared and screened with CT and MRI. Consequently, a mixed hydrophilic 
solution called GadoIodo-EB containing 2 mM gadolinium contrast agent Gd-DOTA 
(Dotarem®, Guerbet, France) for MRI, Iomeprol (Iomeron®, Bracco, Italy) at 10 mg 
iodine/ml for CT and 0.1% Evans blue (EB, Sigma-Aldrich, USA) diluted in normal 
saline was optimized and made ready for instillation into the biliopancreatic duct at 
0.6 ml per rat to demonstrate the pancreas by CT, MRI and visual inspection. 
Furthermore, such solutions of separate components or as a mixture GadoIodo-EB 
were characterized by high-performance liquid chromatography (UV-Vis HPLC 
detector 190-900 nm, Auckland, New Zealand) for testing their chemical stabilities.  
In vivo MRI   
MRI was performed at a 3.0T clinical scanner (Magnetom Tim Trio, Siemens, 
Erlangen, Germany). MR signal was transmitted through the 60 cm size bore body 
coil with maximum gradient amplitude of 45mT/m and slew rate of 200mT/m/ms, 
which was combined with an 8 channel phase array wrist coil as receiver. In vivo and 
postmortem MRI acquisition parameters are summarized in table 1. For in vivo MR 
scanning, animals were anesthetized by inhalation of 1 to 2 % isoflurane (mixed with 
oxygen and air) and placed in a supine position while images were acquired. MR 
compatible small animal physiological monitoring system (SAII, Stony Brook, NY, 
USA) was applied for respiration triggering. A 0.3 mm isotropic 3D gradient echo 
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flash low angle shot (FLASH) sequence with segmented k-space acquisition and a 
flow compensate T2 weighted 3D turbo spin-echo (TSE) with variable-flip-angle 
refocusing RF pulses (SPACE) sequence were performed.  
Postmortem imaging acquisition   
For preparing postmortem studies, rats were first anesthetized with intraperitoneal 
pentobarbital (Nembutal; Sanofi Sante Animale, Brussels, Belgium) at a dose of 40 
mg/kg. After hair shaving and skin sterilization, a midline incision was made to 
expose the liver and other abdominal organs, particularly the hepatic portal area. To 
block the secretion pathway, the biliopancreatic duct was ligated in close vicinity to 
duodenal papilla, similarly to the technique mentioned in Kare’s study (14). 
Afterwards, a 16 cm silicone catheter of 1.0 mm outer diameter (Degania Silicone Ltd, 
Degania Bet, 1513000, Israel) was inserted 6 mm deep into the common bile duct 
(CBD) near the hepatic port to the direction of duodenum for GadoIodo-EB infusion. 
The catheter was anchored with a 5-0 silk suture and connected to a 1.0 ml syringe 
loaded with the GadoIodo-EB contrast medium dye solution. After closure of 
abdominal incision by two layers of suture, the animal was euthanized by intravenous 
overdose of Nembutal to nullify imaging motion artifacts.  
Following a baseline precontrast MRI scanning, pre- and postcontrast CT images 
were acquired on a clinic CT scanner (Somatom Definition Flash, Siemens, Erlangen, 
Germany) using low tube voltage of 80 kVp, total X-ray exposure time was 53s for 
each scan. High resolution transversal imaging was reconstructed and processed in 
Syngo CT 2012B with matrix size of 512*512, and a slice distance of 0.2 mm. Such 
3D-CT scans allowed imaging rat abdomen on a relatively noise-free background to 
validate the presence of contrast agent in the pancreas (see video-supplement 1). 
Postmortem MRI with 3D FLASH sequence was performed to evaluate the T1 
enhancement by Gd-DOTA with isotropic spatial resolution of 0.3 mm, SPACE 
sequence was applied to acquire high-resolution anatomical information for rat 
abdomen, and ultra-short echo time (UTE) sequence was used to highlight tissues 
with short T2 in abdomen. Such 3D MRI scans enabled not only pancreas depiction 
but also neighboring organ localization (see video-supplement 2).  
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Image processing 
All imaging analyses and visualizations were accomplished in MeVisLab platform 
(www.mevislab.de). CT images were co-registered to MRI space using MeVis Image 
Registration Toolkit (MERIT), in which affine transformation using normalized mutual 
information similarity measurements was applied. Afterwards, contrast enhanced 
pancreas was segmented from subtracted T1-weighted MR imaging and resampled 
CT imaging using fuzzy c-mean spatial classification algorithm with a proper intensity 
threshold, followed by region growing approach with 3D-6 nearest neighbor search. 
Segmented pancreas tissue volume was measured automatically.  
Fat distribution in rat abdomen was delineated by subtracting SPACE scans with and 
without spectral fat saturation. Organs surrounding the pancreas were manually 
contoured or segmented semi-automatically from UTE or SPACE images only for 3D 
demonstration of pancreatic topography. Resampled pre-contrast CT bone image 
was used as background scaffold.  
Tissue preparation and histology  
After acquiring all images, animals were reopened to harvest the pancreas organ 
guided by GadoIodo-EB coloration. Dissection was made along the boundaries of the 
blue dye stained pancreatic tissues. The pancreas was cleaned from fat tissue and 
actual pancreatic volume was measured by immersing tissue into distilled water 
within a metering tank. Tissue was fixed in 10% formalin and embedded for paraffin 
sections. Afterwards, 5 µm thickness slices were stained with hematoxylin and eosin 
(HE) for optical microscopic assessment (Axioskop, Zeiss, Oberkoche, Germany) 
and digital photography to compare pancreatic tissues without and with contrast 
injection.  
Image quality assessment 
Signal intensity (SI) was measured within the pancreatic region, and contrast ratio 
(CR) after GadoIodo-EB infusion was calculated by the following equation: CR = 
[SI(post)-SI(pre)]/SI(pre)*100%. Visibility of the pancreas, splenic vein and CBD on 
both MRI and CT were assessed and summarized. 
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Results 
General aspects 
All experimental procedures were carried out smoothly according to the pre-designed 
protocol (Fig. 1) without accidental loss of animals. The clinical CT and MRI imagers 
were adapted well for the purpose of the present study in rats. No apparent variation 
of the pancreas was observed between male and female rats, although a movable 
kidney and an extra rib on the right were encountered in two individual rats as 
anatomical variations among this population. 
Contrast agent solution characterization 
A representative UV chromatogram of mixed contrast medium dye GadoIodo-EB 
consisting of 2.0 mM Gd-DOTA, 10mg Iodine/ml Iomeprol and 0.1% Evans blue dye 
is shown in Figure 2. The profiles clearly revealed only two peaks whose retention 
times (RTs) perfectly matched with those observed by analyzing separate standard 
solutions of Iomeprol and Evans blue dye (data not shown). The sharp peak 
corresponded to the CT agent Iomeprol with a RT of 1.80±0.01 min. The second 
broad peak with a RT of 5.99±0.02 min referred to Evans blue. Neither in the 
standard solution nor in the mixture of GadoIodo-EB could Gd-DOTA be detected 
due to its structural lack of UV chromospher s for the HPLC technique applied. 
However, both peaks of Iomeprol and Evans blue in the mixture were not altered by 
adding Gd-DOTA, of which the presence was affirmed by the MRI studies, indicating 
that no chemical reactions occurred within the mixture of GadoIodo-EB. Phantom 
studies showed that neither the presence of Gd-DOTA on CT nor Iomeprol on MRI 
changed intrinsic signal intensity of the contrast medium dye at their concentrations 
applied. 
In vivo MRI 
Three dimensional high resolution in vivo MRI without contrast enhancement 
displayed abdominal anatomy that could be useful for searching pancreas-related 
landmarks such as the CBD or biliopancreatic duct and splenic vein. For examples, 
on 3D T2 SPACE image, the CBD and its extending biliopancreatic duct appeared 
with a strong hyperintensity (Fig. 3a, table 2) and hypointense splenic vein was 
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shown in full length, which likely goes along with pancreatic body and tail (Fig. 3b,  
table 2), as revealed by later contrasted postmortem studies.  
Contrast enhanced MRI  
Pre- and postcontrast T1 and T2 MRI images are shown with the same anatomic 
positions. On T1 FLASH image, before contrast infusion, there was no difference of 
signal intensities between the pancreas and surrounding organs (Fig. 3c, table 2). 
After GadoIodo-EB infusion, pancreatic region appeared hyperintense, indicating the 
T1-shortening effect of the gadolinium chelate (Fig. 3d, table 2). On T2 SPACE 
images, the pancreas was virtually invisible (Fig. 3c'). But, hyperintense signal 
intensity appeared after GadoIodo-EB infusion due to the presence of saline solvent 
or long-T2 water (Fig. 3d'), because the low-concentrated Gd-DOTA had negligible 
T2--shortening effects.  
CT findings  
Before contrast instillation, the pancreas was invisible when image density was set to 
a threshold value for bone visualization by experienced radiologists (Fig. 4a, 4b). But, 
the infused GadoIodo-EB provided a clear contrast for pancreas alone, displaying it 
as an outstanding organ in abdomen (Fig. 4a’, b’). In addition to the pancreas, 
hyperdense subjects also existed in the abdominal region on pre-contrast CT scan, 
which were proven as calcified food residues within the fecal pellets located in large 
intestines (Fig. 4b, b’ and video supplements).  
Topographic descriptions 
As shown by postmortem contrasted CT and MRI scans in this study (Fig. 3-5), the 
entire pancreas in rats appears as a “T” shaped structure, but tilted 90° to the right, 
with the short vertical bar (pancreatic head) at least 2 times thicker than the long 
horizontal bar (pancreatic body and tail). The entire rat pancreas locates in the upper 
abdomen at the level either between the 11th thoracic vertebra (T11) and the 2nd 
lumbar vertebra (L2) or between the T12 and L3 with slight individual variations (Fig. 
5b, b’ and video supplements). Similar to that of humans, though not in the same 
proportions, the pancreas in rats can be divided into pancreatic head, body and tail. 
The head is further divided into the biliary portion located along the CBD on the right 
side of portal vein and gastric pylorus, and the duodenal portion largely enclosed by 
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the “C” shaped duodenum to the left of the right kidney. The pancreatic body and tail 
form a horizontal entity that is also called gastrosplenic portion located inferior to the 
stomach to the right of the spleen (14) and left kidney (video supplements). 
Contrasted topography of rat pancreas imaging enabled recognizing a few landmarks 
that may help position the pancreas in rats in vivo as described below:  
1) a 2-cm elongation line from the CBD downwards can be referred as a landmark for 
localizing pancreatic head anterior to the hilum of the right kidney and largely 
wrapped by the duodenal loop (Fig. 3a, 5b’);  
2) pancreatic body and tail locate inferoposterior to the stomach and caudate lobes of 
the liver and adjacent to the anterosuperior part of the left kidney (Fig. 5a, a’);  
3) the entire splenic vein joining to the portal vein goes along with pancreatic body 
and tail to the right of the spleen and in front of the left kidney (Fig. 3b, c, c’). 
Their relative positions are illustrated by color-coded imaging extraction (Fig. 5b’). Fat 
tissues can be confused with the pancreas, which could be differentiated by 
highlighting the fat (in purple color) using fat saturated SPACE images (Fig. 5a, a’). 
Segmented pancreas and its landmarks were shown by 3D rending images using the 
bony thorax as a background scaffold (Fig. 5b, b’ and video supplement 2).   
Dissection and histology  
Under a re-laparotomy for ex vivo examinations, digital photos showed Evans blue 
staining of pancreatic tissues (Fig. 6a). Microscopically, pancreatic exocrine tissue, 
expanded pancreatic duct and endocrine islets of Langerhans were identified with 
H&E stained histology. Except slightly dilated exocrine glandular system, there was 
no significant difference between contrast-infused and control pancreases (Fig. 6b, c).  
Quantitative measurements 
After adjusted normalization, pancreatic volumes measured by imaging and ex vivo 
analysis were 1.12 ± 0.04 cm3 and 1.17 ± 0.10 cm3 respectively, which is in line with 
the pancreas weight about 1.2 g for SD rats ranging from 270 to 450 g of body weight 
as reported by a previous study (15). The relative contrast ratio for post-contrast 
FLASH-MRI and CT images was enhanced by 93.28 ± 34.61 % and 26.45 ± 5.29 % 
respectively compared to pre-contrast images (table 2). 
Page 32 of 48
http://mc.manuscriptcentral.com/cmmi
Contrast Media and Molecular Imaging
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
12 
 
 
Discussion 
One bottleneck of research on pancreatic disorders in rodents is the virtual inability to 
noninvasively detect the lesion on this organ, to monitor the disease progress and to 
follow up the therapies by imaging modalities, which has hampered advances in the 
field. As the first step in our serial efforts, we attempted to visualize rat pancreas 
postmortem by contrast enhanced MRI and CT using clinically available imagers. To 
the best of our knowledge, it is the first time that the in situ rodent pancreas is so 
clearly depicted in terms of its location, dimension, contour and relations to the 
adjacent anatomical structures, which may provide useful clues or landmarks for 
identifying rat pancreas and its pathologies during further in vivo pancreatic imaging 
research.     
Currently, CT is still the most commonly used imaging modality for diagnosis of 
pancreatitis and pancreatic tumors due to its temporal efficiency and unbiased 
contrast compared to MRI (16,17). Therefore, we applied CT for cross-reference to 
our MRI findings.  
The utilization of the clinical MRI and CT scanners in combination with the FDA 
approved contrast agents would make our findings more clinically translational. It also 
demonstrates that clinicians in academic institutes could perform preclinical animal 
experiments without relying on the dedicated equipment for small animals. Since the 
achievable spatial resolution could be limited in comparison to the miniaturized 
animal imagers, certain technical optimization was necessary particularly for imaging 
rat pancreas as a tiny irregular abdominal organ. 
Accordingly, we adapted higher resolution 3D scanning protocols to include as many 
details as possible, though such 3D scans were more time-consuming with higher 
imaging noise relative to 2D scans. In this study, both T1 weighted FLASH and T2 
weighted SPACE protocols were applied for contrasted and structural evaluations 
respectively. Results showed that without regional contrast agent instillation, it was 
impossible to distinguish rodent pancreas from the surrounding tissues through those 
imaging protocols.  
Because a real pancreas-specific contrast agent does not exist, in this study we 
prepared a mixed water-soluble solution GadoIodo-EB that consists of two 
extracellular water-soluble contrast agents, Gd-DOTA for MRI and Iomeprol for CT 
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(18,19) both of which do not undergo intracellular uptake, and a blue dye. Once 
infused, the solution with optimized concentrations of gadolinium and iodine was 
filled into the exocrine glandular system, leading to the striking contrast observed 
only in the pancreas on both MRI and CT scans. The postcontrast inhomogeneity of 
MRI signal within the pancreas reflects such intraorganal distribution pattern of Gd-
DOTA as also evidenced on colored dissection. The mixture of these two contrast 
agents with Evans blue dye did not alter their chemical properties as proven by HPLC. 
Since all these 3 components are nontoxic and intravenously injectable in humans, 
and since imaging and HPLC outcomes in our study have implied their inert chemical 
properties while mixed, GadoIodo-EB as a multifunctional diagnostic agent could be 
combined with interventional procedures e.g. endoscopic retrograde 
cholangiopancreatography (ERCP) and laparoscopic cholecystectomy, etc. for 
multimodality imaging diagnosis and/or intraoperative optical imaging observation. 
Such potential clinical applications warrant further experimental investigations. 
Without local contrast instillation, the pancreas shows the same signal intensity or 
tissue density as the liver does. Thus hepatic caudate lobe, which locates closely 
next to the pancreatic body, could be mistaken as the pancreas in the literature (20).  
Indeed, the pancreas shares similar soft tissue imaging features with other abdominal 
organs on both MRI and CT, even after systematical contrast agent administration. 
Therefore, it is essential to track the pancreas in vivo by carefully navigating through 
certain landmarks including adjacent organs and important vessels on 3D images. 
Thus, guided by the artificially contrasted pancreas in this study, we were able to 
identify a few such useful landmarks including the CBD, splenic vein, caudate liver 
lobes, the stomach, the duodenum, the right and left kidney and the spleen, which 
together make the in-between contour of pancreas. Abdominal fat tissues in rats 
especially those adhered to the pancreas could be distinguished by using fat-
saturation MRI sequences. However, omentum tissues appeared more difficult to 
identify, which could only be recognized on histology.   
MRI is known to be superior to CT in soft tissue contrast, but the plain scans of both 
modalities proved insufficient to visualize rodent pancreas, and the use of contrast 
agents was deemed necessary. For this, two obstacles should be tackled. First, since 
pancreas-specific contrast agents do not exist, we had to use commercially available 
nonspecific ones such as Gd-DOTA and Iomeprol for MRI and CT respectively. They 
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are made for intravenous injection at a high concentration. After administration they 
undergo extracellular distribution without intracellular uptake, and tissues or organs 
are properly enhanced by them at much diluted concentrations. If without dilution, the 
presence of CT or MRI contrast agents at their original concentrations (0.5M for Gd-
DOTA and 300mg Iodine/ml for Iomeprol) in the scanned volume would cause strong 
artifacts that would mask the authentic images. This was the reason why we had to 
perform in vitro tests first to optimize the mixed contrast dye GadoIodo-EB for the 
appropriate concentrations of both Gd-DOTA and Iomeprol. Secondly, the presence 
of such a contrast dye had to be confined only in the pancreas but not elsewhere to 
selectively enhance this organ on both CT and MR images. To do so, we took 
advantage of the biliopancreatic anatomy in rats and filled the pancreatic exocrine 
ductal system entirely with GadoIodo-EB so that only the pancreas could be 
outstandingly enhanced on both CT and MRI. 
In order to avoid blooming effect while maintaining adequate contrast enhancement, 
the concentration of each contrast agent used in this study was optimized to a 
clinically acceptable range. The total volume of GadoIodo-EB for infusion into the 
pancreas was also controlled to less than the total volume of pancreas.  
There were rodent pancreatic imaging using micro-CT (9), and specific pancreatic 
labeling using high-resolution SPECT technique (21). Contrast enhanced MRI 
suffered from motion artifact due to the special location of pancreas (22). As 
observed by both imaging and histology, pancreatic head was closely surrounded by 
duodenum and attached to the large intestine, wher  the wave movement was 
unpredictable and cannot be monitored, which leads to blurring artifact of the entire 
region. Therefore, fasting is preferred prior to in vivo imaging to reduce gut 
movements. Besides, fasting for 6 hours leaves more upper abdominal space for 
GadoIodo-EB infusion and eases surgical operation. More specific enhancement on 
inflamed pancreas (23) or pancreatic islets surface reporter (24) may help improve 
the imaging accuracy on the pancreas, however such specific contrast agents are still 
unavailable.  
From our in vivo observations, without contrast enhancement, the CBD showed 
prominent hyperintense on SPACE images. Pancreatic ducts, on the other hand, 
were difficult to highlight due to the limited spatial resolution. Although there are 
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abundant blood supplies to the pancreas, only the splenic vein was thick enough to 
be observed by our imaging sequences. Therefore, it seems also essential for in vivo 
pancreas imaging to apply a contrast agent, ideally a pancreas-specific one.  
In conclusion, visualization of a complete pancreas was achieved through contrast 
enhanced CT and MRI imaging in a novel rat postmortem model. Detailed pancreatic 
landmarks were thus described and demonstrated with 3D rendering, including the 
depicted CBD and splenic vein on in vivo images. To identify other in vivo features of 
rodent pancreas, contrast enhanced protocols will be elaborated in the future. 
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Table 1 MR sequence parameters  
 In Vivo   Post mortem 
Sequence 3D FLASH SPACE   3D FLASH SPACE UTE 
Matrix 256*256*160 256*256*160   256*256*144 256*256*144 176*176*176 
Resolution (mm) 0.29*0.29*0.3 0.29*0.29*0.3   0.29*0.29*0.3 0.29*0.29*0.3 0.43*0.43*0.43 
Bandwidth (Hz/pixel) 275 260   260 230 507 
TE (ms) 3.69 144   3.69 132 0.07 
TR (ms) 487.01 1500   13.74 1500 8.28 
Fat saturation - -/+   - -/+ - 
Flip angles (degree) 10 variable   10 variable 15 
Averages 1 2   1 1.4 1 
GRAPPA 2 3   2 2 off 
Phase Partial Fourier off 67%   off 70% off 
Number of Phase Encoding Steps 256 176   256 183 36000 
Scanning time 7 min 14 min   5 min 8 s 11 min 10 s 4 min 59 s 
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Table 2 Qualitative and quantitative image assessment 
Objects MRI in vivo/pre- MRI post- CT pre- CT post- 
Contrast Ratio % 
Pancreas NA 93.28 ± 34.61 % NA 26.45 ± 5.29 % 
Visibility 
Pancreas ?/12 12/12 0/12 12/12 
Splenic Vein 12/12 NA 0/12 0/12 
CBD 12/12 NA 0/12 0/12 
      Note: pre-: precontrast; post-: postcontrast; NA: not applicable; ?: uncertain.
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Figure legends: 
Figure 1 Flowchart of experimental protocol. n: number of rats; CBD: common bile 
duct; MRI: magnetic resonance imaging; CT: computed tomography; GadoIodo-EB: 
Gd-DOTA, monomeric iodinated contrast agent Iomeprol and Evans blue solution.  
Figure 2 Component chemical structures, vial outlook and HPLC UV-chromatogram 
of the mixed contrast medium dye solution GadoIodo-EB. On HPLC, Iomeprol first 
appeared at a retention time (RT) of 1.80±0.01 min and Evans blue dye came out 
with a RT of 5.99±0.02 min, identical to the respective RT when measured alone. The 
chemical structure of Gd-DOTA did not allow its detection by the applied HPLC 
method. 
Figure 3 Coronal display of rat abdomen. a&b: In vivo T2 SPACE MRI for the 
common bile duct (CBD) and splenic vein. Hyperintense CBD and its distal extension 
of biliopancreatic duct (thick arrow) initiated from the hepatic hilum and extended to 
the gut (a), and hypointense splenic vein (thin arrow) merged into the portal vein (b). 
c-d': Postmortem MRI before and after GadoIodo-EB infusion. Pancreatic tissue 
could not be observed before contrast infusion on both T1 FLASH (c) and T2 SPACE 
(c’) images. Gd-DOTA in GadoIodo-EB solution induced contrast enhancement of 
the pancreas on T1 FLASH image (d), which corresponding to increased signal 
intensity on T2 SPACE image (d’) due to the long T2 water in the solvent. 
Hyperintense pancreatic region outline in FLASH image is delineated by green 
dashed line, the same outline is overlaid to SPACE image. 
Figure 4 Pre- (a, b) and postcontrast (a’, b’) CT images: after GadoIodo-EB infusion , 
the pancreas was clearly shown in the middle of the abdomen on 2D image as 
indicated by arrows and in 3D rendering of postcontrast image. The granules (dashed 
circle) appeared on both pre- and postcontrast scans, indicative of calcified residuals 
of feces in the gut. 
Figure 5 Three dimensional demonstration of postmortem T2 SPACE MRI with color 
coded orthoview of the pancreas (green) and fat distribution (purple) in rat abdomen 
at sagittal, coronal and transverse slice snaps: a. at the plane across pancreatic head, 
body and tail; a’. at the plane only across pancreatic head and tail. The surrounding 
topographic landmarks include stomach (St), caudate liver lobe (Cl), spleen (Sp), 
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right kidney (Rk), left kidney (Lk), and duodenum (Du). Arrows indicate fat tissue 
adjacent to the pancreas, which is otherwise difficult to distinguish. 
Three dimensional rendering topography of the pancreas in rats using re-sampled CT 
to generate bony background scaffold: b. only the pancreas (green) was segmented 
and displayed due to GadoIodo-EB infusion; b’. organs surrounding the pancreas 
(green) were displayed to provide anatomic landmarks including the common bile 
duct (yellow), portal vein (blue), splenic vein (red), spleen (Sp, purple); stomach (St, 
bright grey), kidney (K, cabbage green), and guts (dark grey) with ascending colon 
(Ac), transverse colon (Tc) and descending colon (Dc).  
Figure 6 Dissection and histology: a. digital photograph during autopsy displayed the 
pancreas as an Evans blue stained area adjacent to the stomach (St) and duodenum 
(Du); b&c. H&E stained microscopic view from GadoIodo-EB infused (b) and normal 
(c) pancreatic slices. Arrows indicate exocrine pancreatic tissues and arrowhead 
points to a pancreatic duct, and asterisks refer to islets of Langerhans. Scale bar: 50 
µm. 
Supplemental Digital Content 1 Video that demonstrates pre- and postcontrast CT 
images with 360° rotation. 
Supplemental Digital Content 2 Video that rotationally demonstrates postcontrast 
MRI of segmented pancreas and surrounding topographic landmarks with precontrast 
CT bony thorax used as background scaffold. Refers to Fig. 5 for color coding.  
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